Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Knight Therapeutics Inc
T.GUD
Alternate Symbol(s):
KHTRF
Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select...
international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:GUD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(6)
•••
EbbFlow88
X
View Profile
View Bullboard History
Comment by
EbbFlow88
on Jul 12, 2023 9:58am
RE:New Press Release - Knight Announces Normal Course Issuer Bid
Public float of GUD is 60M shares. 44% of the company is owned by 3 people/groups. It's getting tighter
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jul 12, 2023 7:30am
New Press Release - Knight Announces Normal Course Issuer Bid
MONTREAL, July 12, 2023 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:GUD) ("Knight" or the "Company "), a leading pan-American (ex-US) specialty pharmaceutical company, announced today acceptance by the Toronto Stock Exchange (the "TSX") of the Company's Notice of Intention to Make a Normal...
read article.
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m
posted Nov 13, 2024 9:00am by
Freegold Ventures Limited
-
|
Four specific holes were drilled to facilitate additional metallurgical testing and were strategically designed to collect representative material from the deposit while improving infill drilling efforts. Approximately ~2,400 meters of ½ PQ core (~ 20 tonnes) have been shipped to BaseMet Labs in Kamloops, BC, where a comprehensive suite of metallurgical testing is currently underway ...read more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Post by
Chianchin
on Jul 11, 2023 7:16pm
let's do some math so we can help mugsy
Mugsy claims to have accumulate GUD shares for the past 10 years or so. Let's be kind and assume that mugsy GUD avarage cost is $7. Ha...let's say that the avarage inflation rate is 3
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Post by
Chianchin
on Jul 10, 2023 7:12pm
Mugsy et all
One sep forward two backwords investor mugsy and aliases will never understand that the buy back has not worked and will not work for GUD shareholders. But for mugsy it does not matter he/she/the has
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jul 06, 2023 6:20pm
RE:June buybacks
Yes - looking forward to when we're below 100 MM in share count. That's one benefit of the price staying down here - GUD willing to keep going with the buybacks.
(6)
•••
EbbFlow88
X
View Profile
View Bullboard History
Post by
EbbFlow88
on Jul 05, 2023 9:15am
June buybacks
We should be below 107M shares now with another 776,700 shares cancelled. NCIB should also be renewed next week.
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Jun 29, 2023 3:53pm
Interesting price range expectations -curious for comments
GUD Stock 12 Months Forecast Based on 5 Wall Street analysts offering 12 month price targets for Knight Therapeutics in the last 3 months. The average price target is C$6.67 with a high forecast
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jun 26, 2023 7:43pm
RE:The gambler or investor
hahaha - mugsy isn't running anywere. he's very content. Sorry ChiChi - I'm a little preoccupied with a new drug reformulation right now. It's taking all of my pretty little pennies.
...more
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Jun 26, 2023 9:34am
Golden Age for pharma & Biotech
Being discussed strength of industry & growth of all products on CNBC. focus on strength of products and innovation. GUD times.
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Post by
Chianchin
on Jun 23, 2023 7:46am
Argentina doing well
https://www.bloomberg.com/news/articles/2023-06-23/whirlpool-among-firms-in-argentina-considering-china-yuan-on-us-dollar-shortage?srnd=premium-canada
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Post by
Chianchin
on Jun 22, 2023 8:31pm
The gambler or investor
You got to know when to hold, got to know when to fold, got to know mugsy is running
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Post by
Chianchin
on Jun 16, 2023 9:27pm
Recapping the week.. results
Gud lower Mugsy higher
(6)
•••
curiousj
X
View Profile
View Bullboard History
Comment by
curiousj
on Jun 16, 2023 9:37am
RE:Jeff Martens - VP of GLOBAL COMMERCIAL OPERATIONS
he's been in that role. director of marketing got elevated over him
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Jun 15, 2023 12:54pm
Jeff Martens - VP of GLOBAL COMMERCIAL OPERATIONS
Elevated to a more senior role, as he and the rest of the GUD team at Knight evolve & the team grows. Knight is growing, evolving, getting busier. seems to be a very GUD thing... continued
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Meet the Top 5 Best Online Brokerages in Canada
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023
Gold, growth and sustainability in focus for this resource company
Star Diamond Corporation Announces Third Quarter 2024 Results
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
Explained: The Psychology of Options Trading with Practical Tips